2 results
Approved WMORecruiting
Primary- Continuation of treatment- SafetySecondairy- Documentation of tolerability
Approved WMOCompleted
The primary objective of this study is to provide extended access to momelotinib (MMB) and assess long-term safety in 4 cohorts of subjects who are currently receiving treatment with MMB and have not experienced progression of disease:* Cohort 1:…